Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 0% |
 |
Gilead SciencesGILD |
60 3.4% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Nov 2024 | 0 | |
| Oct 2024 | 0 | |
| Sep 2024 | 0 |
How do employees feel about the future at I-Mab?
According to employees, the Business Outlook at I-Mab is highly negative. This is reflected in the average rating of 0 out of 100, which is considered very low.
Analyzing Business Outlook, how is I-Mab performing compared to its industry peers?
I-Mab underperforms its industry peers when it comes to Business Outlook, ranking dead last.
How has the business outlook at I-Mab changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at I-Mab.
Why is it important to track the business outlook at I-Mab?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at I-Mab.
